Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

1,197 evidence items · page 23 / 48

95 %Various other studies observed an antibody response of 95% from their COVID-19 patients.

MaliCOVID-19HAL · Unilimdocument of 67 observations

95 %Diagnostic performances to identify sickle cell disease carriers exceeded 95% for both rapid diagnostic tests.

MalidrépanocytoseHAL · Unilimdocument of 103 observations

1.9 per_1000Seasonal malaria chemoprevention reduced malaria incidence by 1.9 per 1000 for an adjusted coverage rate from 30.0 to 80.0%.

Malipaludismeobserved April 2017 to March 2022HAL · Unilimdocument of 111 observations

16 %The reduced function allele CYP2C8*2 was most common in West and Central Africa with frequencies of 16% to 36.9%.

Malipaludismepublished 2024Human genomicseurope_pmcdocument of 3 observations

20 %Efficacy of the malaria vaccine FMP2.1/AS02(A) against clinical malaria defined on various parasite-density thresholds was approximately 20% in Malian children.

Malipaludismepublished 2011The New England journal of medicineeurope_pmcdocument of 5 observationsDOI 10.1056/nejmoa1008115

57 %Le nombre de cas de P. knowlesi représentait 57 % en 2013 des infections paludéennes en Malaisie.

MaliP. knowlesiobserved 2013HAL · Unilimdocument of 214 observations

25.81 %La prévalence du paludisme clinique chez les enfants âgés de 5 à 9 ans était de 25,81 %.

MalipaludismeHAL · Unilimdocument of 214 observations

0.25 µMPlasmodium vivax schizont stages were fully susceptible to atovaquone at 0.25µM.

Malipaludismepublished 2023BMC infectious diseaseseurope_pmcdocument of 4 observations

22.41 %La prévalence du paludisme pour toutes les espèces de Plasmodium était de 22,41 % (IC à 95 % : 16,60–28,79 %) lors du dépistage actif.

MalipaludismeHAL · Unilimdocument of 214 observations

8.9 %The non-specific binding of antibody samples in COVID-19 patients accounted for 8.9% (17 out of 189) of the seroreactive samples for S.

MaliCOVID-19HAL · Unilimdocument of 67 observations

95.22 %The sensitivity of HemotypeSC® for detecting sickle cell trait was 95.22% (95% CI: 93.74–96.70).

Malitrait drépanocytaireHAL · Unilimdocument of 103 observations

12.8 %The proportion of severe pneumonia among children aged 2–59 months was 12.8% (69/707) in Mali.

Malipneumonie sévèreobserved 14 June 2021 to 20 June 2022HAL · Unilimdocument of 187 observations

23.4 %Prevalence of parasitaemia was 23.4% in the intervention district prior to seasonal malaria chemoprevention (SMC).

Maliparasitemiaobserved July 2014published 2017Malaria journaleurope_pmcdocument of 10 observations

4 mg/LSqualamine showed in vitro activity against dermatophytes with minimum inhibitory concentrations (MICs) ranging from 4 to 16 mg/L.

Malidermatophyte infectionspublished 2013Medical mycologyeurope_pmcdocument of 2 observations

1 per_100Au Mali, P. ovale est responsable de 1 % des cas de paludisme.

MalipaludismeHAL · Unilimdocument of 214 observations

1 per_1000_person_weeksIn 2024, rainfall was more intense and concentrated, with a significantly higher peak in malaria cases per 1,000 person-weeks than in previous years.

Malipaludismeobserved 2024HAL · Unilimdocument of 80 observations

1.4 %1.4% of individuals in the MIM profile strongly agreed that COVID-19 was a divine punishment.

MaliCOVID-19HAL · Unilimdocument of 88 observations

90 %Both RDTs had an area under the curve greater than 90% for identifying confirmed sickle cell disease.

MalidrépanocytoseHAL · Unilimdocument of 103 observations

0.19 hazard_ratioIn a cohort study in Bandiagara, Mali, from June 2009 to June 2010, hemoglobin AC children had a hazard ratio of 0.19 for first clinical malaria episode compared to hemoglobin AA children.

Malipaludismeobserved June 2009 to June 2010published 2015The Journal of infectious diseaseseurope_pmcdocument of 10 observationsDOI 10.1093/infdis/jiv308

25.81 %Chez les enfants âgés de 5 à 9 ans, la charge de paludisme était de 25,81 %.

MalipaludismeHAL · Unilimdocument of 214 observations

22.41 %La prévalence du paludisme due à toutes les espèces de Plasmodium était de 22,41 % lors du dépistage actif dans la commune rurale de Ntjiba, Mali, entre 2016 et 2021.

Malipaludismeobserved 2016 à 2021HAL · Unilimdocument of 214 observations

532 casesIn Tombouctou health district, there were over 532 confirmed cases of COVID-19, representing 0.76% of the general population.

MaliCOVID-19HAL · Unilimdocument of 88 observations

10.9 %La fréquence de la neuropathie sensitivo-motrice dans une population générale au Mali était de 10,9 % en 2013.

Malineuropathie périphériqueobserved 2013HAL · Unilimdocument of 747 observations

Une corrélation positive entre le niveau plasmatique de produits avancés de protéines oxydées et la susceptibilité au paludisme a été décrite chez les enfants de moins de 2 ans.

MalipaludismeHAL · Unilimdocument of 31 observations

99.4 %Among 3676 liveborn newborns from consenting mothers in Mali between April and August 2021, 3655 (99.4%) were enrolled in the newborn screening study.

Malidrépanocytoseobserved April–August 2021HAL · Unilimdocument of 103 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.